Unlocking Cancer Therapies: Your Guide to Pharmaceutical Intermediate 2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-Enecarbaldehyde CAS 1228837-05-5
Discover the critical role of this high-purity pharmaceutical intermediate in advancing cancer treatment research and development.
Get a Quote & SampleProduct Core Value
2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-Enecarbaldehyde CAS 1228837-05-5
This advanced pharmaceutical intermediate, identified by CAS No. 1228837-05-5, is a pivotal compound in the synthesis pathway of Venetoclax, a leading targeted therapy in oncology. Its precise chemical structure (C15H17ClO) and high purity, backed by GMP, ISO 9001, and FDA certifications, make it indispensable for pharmaceutical research and the production of life-saving cancer treatments.
- Leverage our high-purity 2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-Enecarbaldehyde CAS 1228837-05-5 for reliable synthesis of Venetoclax.
- Ensure research accuracy with a pharmaceutical intermediate (C15H17ClO) essential for cancer therapy development.
- Benefit from a chemical intermediate crucial for the synthesis of Venetoclax, a key component in cutting-edge cancer treatments.
- Source with confidence, knowing this Venetoclax intermediate is produced under stringent quality standards, including GMP, ISO 9001, and FDA.
Key Advantages
Uncompromised Purity for Research
Our pharmaceutical intermediate guarantees exceptional purity, vital for achieving precise and reproducible results in R&D for cancer drugs like Venetoclax.
Streamlined Synthesis of Venetoclax
Facilitate the complex synthesis of Venetoclax, a critical drug for leukemia patients, by utilizing a high-quality, reliable intermediate.
Versatile Application in Drug Discovery
This chemical intermediate is not only essential for Venetoclax but also serves as a valuable component in broader pharmaceutical intermediate research and development.
Key Applications
Pharmaceutical Synthesis
As a critical pharmaceutical intermediate, it plays a vital role in the precise synthesis of active pharmaceutical ingredients (APIs), including the anti-cancer drug Venetoclax.
Cancer Drug Intermediate
Essential for the production of Venetoclax, this intermediate is key to developing advanced therapies for various forms of leukemia and other blood cancers.
Laboratory Reagent
Its well-defined chemical properties make it a reliable laboratory reagent for analytical purposes and a building block in organic chemistry research.
Scientific Research
Supports ongoing scientific research in medicinal chemistry, contributing to the development of new treatments and the understanding of molecular mechanisms in disease.